Staging & Prognosis of Lung Cancer

The extent of lung cancer is described as its stage, and this is important in deciding on the appropriate treatment and the likely prognosis of the disease.

In the case of non small cell lung cancer, early stage disease (stage I and II) can often be treated surgically, whereas more advanced disease is treated more commonly with chemotherapy and/or radiotherapy. Five year survival rates show a range from 60% for Stage I, to less than 10% for Stage IV disease.

Small cell lung cancer is treated with chemotherapy and radiotherapy, with little role for surgery. However long-term survival rates remain poor with only 15-20% of patients with limited disease surviving 5 years or more and less than 10% of those with extensive disease at presentation are alive at 5 years.

Very few patients with mesothelioma are considered for surgery and treatment is palliative with the aim of symptom control.

Survival from the time of diagnosis is approximately 7-12 months, with fewer than 5% of patients living beyond 5 years.

"My heartfelt thanks and gratitude for your care of my son. He is now back to normal and enjoying life with his wife and family"
Mr MAS, Lahore

Read more patient journeys

Clinical Team

Here for you

Prof Nutting treats both private and NHS patients, learn about the practice and Prof Nutting's clinical teams here.


Arrange a Consultation

Complete our simple contact form
to get in touch.